Burden of Group B Streptococcus (GBS)

Estimating the Burden of Group B Streptococcus infections globally – ‘GBS’ (2015-2017)
We are conducting a ‘landscape analysis’, looking at the global epidemiology of this invasive pathogen in terms of it’s contribution to Newborn and Infant sepsis, Stillbirths, Neurological Impairment, and other outcomes such as Prematurity and Neonatal encephalopathy.
This research will aim to estimate the importance of GBS globally, which will be crucial for understanding the potential benefit of a GBS vaccine given to pregnant women, similar to Maternal Tetanus Vaccination for example.
Maternal GBS vaccines are reaching more advanced stages in development, and therefore this currently becoming more pertinent.

 

Comments are closed.